The therapeutic efficacy of CPLJ and fractions in mitigating Cyp-induced thrombocytopenia in rat models was discovered by morphological evaluation of megakaryocytes in the bone marrow and histopathology of the liver and kidney [2]. The gene discussed is PPIG; the disease is Thrombocytopenia.